Literature DB >> 15190523

The case for hepatitis C arthritis.

Itzhak Rosner1, Michael Rozenbaum, Elias Toubi, Aharon Kessel, Jochanan E Naschitz, Eli Zuckerman.   

Abstract

OBJECTIVE: To present the data available supporting the existence of an arthropathy associated with hepatitis C infection.
METHODS: The MEDLINE database was searched for "arthritis" intersecting with "hepatitis C" in addition to the authors' investigations and experience on this subject.
RESULTS: Arthritis, not otherwise explained, has been noted in 2% to 20% of hepatitis C virus (HCV) patients. This arthritis is rheumatoid-like in two thirds of the cases and a waxing/waning oligoarthritis in the rest. Cryoglobulinemia alone does not explain the arthritis, and there is difficulty in differentiating it from rheumatoid arthritis. The arthropathy is nonerosive/nondeforming. Whereas nonsteroidal anti-inflammatory drugs, low-dose corticosteroids, and hydroxychloroquine may be helpful, conventional treatment of arthritis may be problematic in the context of viral hepatitic arthropathy. Antiviral therapy is most effective, even without viral clearance, but rheumatic complications may ensue.
CONCLUSIONS: HCV arthropathy should be considered in the differential diagnosis of new-onset arthritis.

Entities:  

Mesh:

Year:  2004        PMID: 15190523     DOI: 10.1016/j.semarthrit.2003.12.006

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  17 in total

1.  Hepatitis C virus treatment complicated by rheumatoid arthritis.

Authors:  Meredith Borman; Mark G Swain
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

2.  Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.

Authors:  M Zehairy; E Soliman; A Daghaidy
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

3.  Hepatitis C virus infection and its rheumatologic implications.

Authors:  Zeynel A Sayiner; Uzma Haque; Mohammad U Malik; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

4.  Anti-cyclic citrullinated Peptide frequency in patients with chronic hepatitis C virus infection and effect of presence of systemic disease.

Authors:  Ayse Albayrak; Hakan Dursun; Muhammet Hamidullah Uyanik; Serkan Cerrah
Journal:  Eurasian J Med       Date:  2012-12

5.  Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver.

Authors:  Ali Aydeniz; M Namiduru; I Karaoglan; O Altindag; E Yagiz; S Gursoy
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

6.  Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.

Authors:  Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth Clipp
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

Review 7.  Viral arthritis.

Authors:  Michael Marks; Jonathan L Marks
Journal:  Clin Med (Lond)       Date:  2016-04       Impact factor: 2.659

Review 8.  Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Authors:  Carlo Palazzi; Emilio D'Amico; Salvatore D'Angelo; Michele Gilio; Ignazio Olivieri
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

9.  Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases.

Authors:  S Aslanidis; T Vassiliadis; A Pyrpasopoulou; I Douloumpakas; C Zamboulis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 3.650

10.  Hepatitis C virus infection and autoimmune diseases.

Authors:  Marino Paroli; Gino Iannucci; Daniele Accapezzato
Journal:  Int J Gen Med       Date:  2012-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.